Cancer Letters
Volume 210, Issue 1 , Pages 73-80 , 8 July 2004

A new polyclonal antibody that recognizes a human receptor for hyaluronan mediated motility

  • Hiroko Kuwabara

      Affiliations

    • Second Department of Pathology, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-72-683-1221; fax: +81-72-684-6514
    • ,
  • Masahiko Yoneda

      Affiliations

    • Biochemistry and Molecular Biology Laboratory, Aichi Prefectural College of Nursing and Health, Aichi 463-8502, Japan
    • ,
  • Masami Nagai

      Affiliations

    • Department of Internal Medicine, Kagawa University Medical School, Kagawa 761-0793, Japan
    • ,
  • Hana Hayasaki

      Affiliations

    • Department of Anatomy, Osaka Medical College, Osaka 569-8686, Japan
    • ,
  • Hiroshi Mori

      Affiliations

    • Second Department of Pathology, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan

Received 24 October 2003 ,Revised 6 January 2004 ,Accepted 9 January 2004.

References 

  1. Turley EA, Moore D, Hayden LJ. Characterization of hyaluronate binding proteins isolated from 3T3 and murine sarcoma virus transformed 3T3 cells. Biochemistry. 1987;26:2997–3005
  2. Turley EA, Belch AJ, Poppema S, Pilarski LM. Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood. 1993;81:446–453
  3. Greiner J, Ringhoffer M, Taniguchi M, Schmitt A, Kirchner D, Krahn G, et al. Receptor for hyaluronic acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia. Exp. Hematol. 2002;30:1029–1035
  4. Assmann V, Gillett CE, Poulsom R, Ryder K, Hart IR, Hanby AM. The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells. J. Pathol. 2001;195:191–196
  5. Assmann V, Kern HF, Elsasser HP. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells. Clin. Cancer Res. 1996;2:1607–1618
  6. Teder P, Bergh J, Heldin P. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines. Cancer Res. 1995;55:3908–3914
  7. Turley EA, Austen L, Vandeligt K, Clary C. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J. Cell Biol. 1991;112:1041–1047
  8. Assmann V, Jenkinson D, Marshall JF, Hart IR. The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments. J. Cell Sci. 1999;112:3943–3954
  9. Maxwell CA, Keats JJ, Crainie M, Sun X, Yen T, Shibuya E, et al. RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. Mol. Biol. Cell. 2003;14:2262–2276
  10. Hofmann M, Fieber C, Assmann V, Gottlicher M, Sleeman J, Plug R, et al. Identification of IHABP, a 95 kDa intracellular hyaluronic binding protein. J. Cell Sci. 1998;111:1673–1684
  11. Wang C, Thor AD, Moore DH, Zhao Y, Kerschmann R, Stern R, et al. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin. Cancer Res. 1998;4:567–576
  12. Kuwabara H, Nagai M, Kawakami K, Ohmori M, Tasaka T, Funamoto Y, et al. Establishment and characterization of a Kaposi's sarcoma-associated herpesvirus- and Epstein-Barr virus-negative malignant lymphoma cell line (OHK) with primary effusion lymphoma immunophenotype. Br. J. Haematol. 2002;116:128–134
  13. Pilarski LM, Miszta H, Turley EA. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells. J. Immunol. 1993;150:4292–4302
  14. Yu Q, Toole BP. Biotinylated hyaluronan as a probe for detection of binding proteins in cells and tissues. Biotechniques. 1995;19:122–129
  15. Assmann V, Marshall JF, Fieber C, Hofmann M, Hart IR. The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J. Cell Sci. 1998;111:1685–1694
  16. Toole BP. Proteoglycans and hyaluronan in morphogenesis and differentiation. In:  Hay ED editors. Cell Biology of Extracellular Matrix. 1991:New York: Plenum Press; 1991;p. 305–342
  17. Kuwabara H, Yoneda M, Nagai M, Nishio H, Tasaka T, Suzuki K, et al. High levels of hyaluronan production by a malignant lymphoma cell line with primary effusion lymphoma immunophenotype OHK. Br. J. Haematol. 2003;120:1055–1057
  18. Crainie M, Belch AR, Mant MJ, Pilarski LM. Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants. Blood. 1999;93:1684–1696
  19. Masellis-Smith A, Belch AR, Mant MJ, Turley EA, Pilarski LM. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Blood. 1996;87:1891–1899
  20. Cheung WF, Cruz TF, Turley EA. Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. Biochem. Soc. Trans. 1999;27:135–142
  21. Saito H, Lai J, Rogers R, Doerschuk CM. Mechanical properties of rat bone marrow and circulating neutrophils and their responses to inflammatory mediators. Blood. 2002;99:2207–2213

PII: S0304-3835(04)00045-X

doi: 10.1016/j.canlet.2004.01.004

Cancer Letters
Volume 210, Issue 1 , Pages 73-80 , 8 July 2004

Article Tools

* Image Usage & Resolution